Logo image of ACHL

ACHILLES THERAPEUTICS PL-ADR (ACHL) Stock Earnings & Estimates

NASDAQ:ACHL - US00449L1026 - ADR

1.48 USD
+0.01 (+0.68%)
Last: 3/20/2025, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
ACHL revenue by date.ACHL revenue by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
YoY % growth
ACHL ebitda by date.ACHL ebitda by date.
-6.73M-13.48M
-100.30%
-32.96M
-144.51%
-60.91M
-84.80%
-74.19M
-21.80%
-70.542M
4.92%
N/A
-2.21%
N/A
-38.96%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ACHL ebit by date.ACHL ebit by date.
-6.9M-13.78M
-99.71%
-33.73M
-144.78%
-64.2M
-90.34%
-77.88M
-21.31%
-75.255M
3.37%
N/A
-2.83%
N/A
-36.98%
N/A
49.73%
N/A
-20.00%
N/A
-20.00%
N/A
-143.22%
N/A
-7.65%
N/A
22.34%
Operating Margin
ACHL operating margin by date.ACHL operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ACHL eps by date.ACHL eps by date.
N/AN/AN/A-9.62-1.82
81.08%
-1.74
4.40%
N/A
89.45%
N/A
33.33%
N/A
-2,183.33%
N/A
47.81%
N/A
-17.48%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.37
20.17%
-0.32
-5.40%
-0.24
40.29%
-0.17
63.88%
-0.16
55.56%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
-24.072M
-62.64%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-24.072M
-23.36%
-13.77M
3.70%
-10.71M
39.83%
-7.65M
62.53%
-7.14M
70.34%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.48
-14.29%
-0.42-0.06-14.78%
Q2 2024
Q2Q % growth
-0.41
2.38%
-0.420.011.96%
Q1 2024
Q2Q % growth
-0.30
31.82%
-0.470.1736.52%
Q4 2023
Q2Q % growth
-0.46
24.59%
-0.15-0.31-211.02%
Q3 2023
Q2Q % growth
-0.42
-31.25%
-0.41-0.01-2.94%
Q2 2023
Q2Q % growth
-0.42
4.55%
-0.430.011.18%
Q1 2023
Q2Q % growth
-0.44
2.22%
-0.41-0.03-7.17%
Q4 2022
Q2Q % growth
-0.61
-35.56%
-0.42-0.19-45.86%
Q3 2022
Q2Q % growth
-0.32
5.88%
-0.560.2442.44%
Q2 2022
Q2Q % growth
-0.44
2.22%
-0.570.1322.69%
Q1 2022
Q2Q % growth
-0.45
94.63%
-0.520.0712.64%
Q4 2021
Q2Q % growth
-0.45 -0.41-0.04-8.66%
Q3 2021
Q2Q % growth
-0.34 -0.490.1530.84%
Q2 2021
Q2Q % growth
-0.45 -0.500.0510.69%
Q1 2021
Q2Q % growth
-8.38 -3.32-5.07-152.79%
ACHL Yearly EPS VS EstimatesACHL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6 -8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ACHL Yearly Revenue VS EstimatesACHL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2031 20M 40M 60M 80M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 5.26% 0% 88.54%
RevenueN/A N/A N/A N/A